Panchsheel Organics
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Panchsheel Organics scheduled its 37th annual general meeting for 30 September 2026 at 3pm through video conferencing, with remote e-voting running from 27 to 29 September. Shareholders were asked to approve a final dividend of ₹0.80 a share, reappoint director Rajesh Turakhia and appoint Harshal Doshi & Associates as statutory auditor for five years. The notice sought approval for FY27 related-party transactions, including ₹10 crore of services and ₹5 crore each of purchases and sales with Suneeta Chemicals, alongside transactions with Turakhia Bros, Gene Biotech, Paramount Organics, Synodrug & Intermediates and Pan-India Drugs & Chemicals. Kishor Turakhia was proposed as managing director for five years from 30 September, while Chandan Turakhia was proposed for regularisation as a non-executive director. Panchsheel Organics had reported FY26 revenue of ₹106.78 crore and net profit of ₹10.83 crore.
Powered by Tijori
Panchsheel Organics scheduled its 37th annual general meeting for 30 September 2026 at 3pm through video conferencing, with remote e-voting running from 27 to 29 September. Shareholders were asked to approve a final dividend of ₹0.80 a share, reappoint director Rajesh Turakhia and appoint Harshal Doshi & Associates as statutory auditor for five years. The notice sought approval for FY27 related-party transactions, including ₹10 crore of services and ₹5 crore each of purchases and sales with Suneeta Chemicals, alongside transactions with Turakhia Bros, Gene Biotech, Paramount Organics, Synodrug & Intermediates and Pan-India Drugs & Chemicals. Kishor Turakhia was proposed as managing director for five years from 30 September, while Chandan Turakhia was proposed for regularisation as a non-executive director. Panchsheel Organics had reported FY26 revenue of ₹106.78 crore and net profit of ₹10.83 crore.
Powered by Tijori
Panchsheel Organics said its Managing Director and promoter, Mr. Mahendra Abhaychand Turakhia, died on August 1, 2026. He held 21,20,672 shares, representing 16.10% of the company's equity. The company described the loss as irreparable.
Powered by Tijori
Panchsheel Organics said its Managing Director and promoter, Mr. Mahendra Abhaychand Turakhia, died on August 1, 2026. He held 21,20,672 shares, representing 16.10% of the company's equity. The company described the loss as irreparable.
Powered by Tijori
Feb 28 (Reuters) - Panchsheel Organics Ltd PANO.BO:
PANCHSHEEL ORGANICS LTD - APPROVED PROPOSAL TO ACQUIRE A FACTORY PREMISES WORTH OF 29 MILLION RUPEES
PANCHSHEEL ORGANICS LTD - APPROVED PROPOSAL TO ACQUIRE FACTORY PREMISES FOR EXPANSION PURPOSE
Source text for Eikon: ID:nBSE4PtjHy
Further company coverage: PANO.BO
(([email protected];))
Feb 28 (Reuters) - Panchsheel Organics Ltd PANO.BO:
PANCHSHEEL ORGANICS LTD - APPROVED PROPOSAL TO ACQUIRE A FACTORY PREMISES WORTH OF 29 MILLION RUPEES
PANCHSHEEL ORGANICS LTD - APPROVED PROPOSAL TO ACQUIRE FACTORY PREMISES FOR EXPANSION PURPOSE
Source text for Eikon: ID:nBSE4PtjHy
Further company coverage: PANO.BO
(([email protected];))
Feb 13 (Reuters) - Panchsheel Organics Ltd PANO.BO:
RESIGNATION OF GAURANG PATEL AS CFO
APPOINTS DEEPAK SHAH AS CFO
Source text for Eikon: ID:nBSE7ZJWHy
Further company coverage: PANO.BO
(([email protected];))
Feb 13 (Reuters) - Panchsheel Organics Ltd PANO.BO:
RESIGNATION OF GAURANG PATEL AS CFO
APPOINTS DEEPAK SHAH AS CFO
Source text for Eikon: ID:nBSE7ZJWHy
Further company coverage: PANO.BO
(([email protected];))
April 10 (Reuters) - Panchsheel Organics Ltd PANO.BO:
CHANDRAKANT SHAH CEASES TO BE CFO DUE TO DEMISE
Source text for Eikon: ID:nBSE7wLvVG
Further company coverage: PANO.BO
(([email protected];))
April 10 (Reuters) - Panchsheel Organics Ltd PANO.BO:
CHANDRAKANT SHAH CEASES TO BE CFO DUE TO DEMISE
Source text for Eikon: ID:nBSE7wLvVG
Further company coverage: PANO.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Panchsheel Organics do?
Panchsheel Organics, a manufacturer and exporter of pharmaceutical products with over 30 years of experience, specializes in APIs, Intermediates & Finished Formulations. Compliant with Schedule 'M', GMP & WHO standards, the company aims for innovative production and market leadership.
Who are the competitors of Panchsheel Organics?
Panchsheel Organics major competitors are Kimia Biosciences, Balaxi Pharma., Alpa Laboratories, Krebs Biochem.&Inds, Achyut Healthcare, Vaidya Sane Ayur Lab, Makers Laboratories. Market Cap of Panchsheel Organics is ₹144 Crs. While the median market cap of its peers are ₹129 Crs.
Is Panchsheel Organics financially stable compared to its competitors?
Panchsheel Organics seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Panchsheel Organics pay decent dividends?
The company seems to pay a good stable dividend. Panchsheel Organics latest dividend payout ratio is 30.56% and 3yr average dividend payout ratio is 30.44%
How has Panchsheel Organics allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Panchsheel Organics balance sheet?
Balance sheet of Panchsheel Organics is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Panchsheel Organics improving?
No, profit is decreasing. The profit of Panchsheel Organics is ₹10.3 Crs for TTM, ₹13.79 Crs for Mar 2025 and ₹14.11 Crs for Mar 2024.
Is the debt of Panchsheel Organics increasing or decreasing?
Yes, The net debt of Panchsheel Organics is increasing. Latest net debt of Panchsheel Organics is ₹1.82 Crs as of Mar-26. This is greater than Mar-25 when it was -₹3.32 Crs.
Is Panchsheel Organics stock expensive?
Panchsheel Organics is not expensive. Latest PE of Panchsheel Organics is 13.97, while 3 year average PE is 19.02. Also latest EV/EBITDA of Panchsheel Organics is 11.17 while 3yr average is 14.25.
Has the share price of Panchsheel Organics grown faster than its competition?
Panchsheel Organics has given lower returns compared to its competitors. Panchsheel Organics has grown at ~-25.49% over the last 4yrs while peers have grown at a median rate of -1.41%
Is the promoter bullish about Panchsheel Organics?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Panchsheel Organics is 56.12% and last quarter promoter holding is 56.12%.
Are mutual funds buying/selling Panchsheel Organics?
There is Insufficient data to gauge this.